Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NimBio logo — Enabling Remote Care for Immune-Mediated Diseases

NimBio

Enabling Remote Care for Immune-Mediated Diseases

Founded 2022 7 employees Pre-Seed Total: $880.00K Biotechnology, Health Care

General Information

Company Name NimBio
Founded Year 2022
Employees 7
Industries Biotechnology, Health Care
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with NimBio. To contact NimBio, visit nimbio.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About NimBio

NimBio, with the slogan "Enabling Remote Care for Immune-Mediated Diseases," aims to revolutionize care for inflammatory bowel diseases by addressing the unpredictable and severe nature of flares. The company provides continuous monitoring and predictive analytics to accelerate time-to-care decisions, ensuring timely intervention and mitigating potential long-term health effects. NimBio's solution fills a critical gap in the current healthcare landscape, offering the health system a vital advantage in improving patient outcomes and optimizing care delivery. Founded in 2022, NimBio operates in the Biotechnology and Health Care industries. In their last financing round, they secured $880.00K in a Pre Seed Round investment on 10 November 2022 from eHealth Ventures.

Taxonomy: Remote care, Predictive analytics, Chronic disease management, Patient monitoring, Inflammatory bowel diseases, Health outcomes, Care delivery optimization, Digital health, Medical technology, Healthcare innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $880.00K 1
eHealth Ventures
eHealth Ventures
10 Nov 2022

NimBio Alternatives & Competitors

View All Alternatives
NimBio vs
Bio Conscious Technologies Inc.
Bio Conscious Technologies Inc. Canada

Prevention as a Service™

Seed
11 employees
AI, Biotechnology
NimBio vs
Nanomed Diagnostic Biotechnology
Nanomed Diagnostic Biotechnology Turkey

Better & Beyond

5 employees
Biotechnology, Deep Tech
NimBio vs
Neurobit
Neurobit United States

Neurobit is building a Universal health analytics platform using sleep as a biomarker across age, ge...

Angel
7 employees
AI, Biotechnology
View all alternatives

FAQ About NimBio

Enabling Remote Care for Immune-Mediated Diseases
NimBio was founded in 2022.
NimBio operates in Biotechnology and Health Care. Its work centres on Remote care, Predictive analytics, Chronic disease management and Patient monitoring.
NimBio has approximately 7 employees.
NimBio has completed 1 funding round, raising a total of $880.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to NimBio include Bio Conscious Technologies Inc., Nanomed Diagnostic Biotechnology, Neurobit, FimmCyte, Solis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NimBio and Bio Conscious Technologies Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NimBio, https://bouncewatch.com/company/nimbio, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes